DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,487 filers reported holding DANAHER CORPORATION in Q1 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $203,577 | -11.5% | 767 | -14.0% | 0.09% | -15.2% |
Q3 2022 | $230,000 | -9.1% | 892 | -10.5% | 0.10% | -2.8% |
Q2 2022 | $253,000 | -15.7% | 997 | -2.4% | 0.11% | -0.9% |
Q1 2022 | $300,000 | -15.0% | 1,022 | -4.7% | 0.11% | -8.4% |
Q4 2021 | $353,000 | +1.4% | 1,072 | -6.1% | 0.12% | -4.0% |
Q3 2021 | $348,000 | +3.6% | 1,142 | -8.8% | 0.12% | +13.8% |
Q2 2021 | $336,000 | +10.5% | 1,252 | -7.4% | 0.11% | +6.9% |
Q1 2021 | $304,000 | -15.1% | 1,352 | -16.1% | 0.10% | -16.4% |
Q4 2020 | $358,000 | -27.2% | 1,612 | -29.5% | 0.12% | -33.7% |
Q3 2020 | $492,000 | +14.7% | 2,287 | -5.7% | 0.18% | +7.6% |
Q2 2020 | $429,000 | +15.6% | 2,425 | -9.4% | 0.17% | 0.0% |
Q1 2020 | $371,000 | -26.2% | 2,678 | -18.3% | 0.17% | -11.9% |
Q4 2019 | $503,000 | -46.0% | 3,279 | -49.1% | 0.19% | -48.8% |
Q3 2019 | $931,000 | +19.4% | 6,445 | +18.1% | 0.38% | +16.3% |
Q2 2019 | $780,000 | – | 5,457 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |